Ligand validation:4IBL

BGC: beta-D-glucopyranose

BGC is a Ligand Of Interest in 4IBL designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4IBL_BGC_L_201	61%	77%	0.103	0.89	0.27	0.63	-	-	0	0	100%	0.9167
3TH2_BGC_L_143	74%	26%	0.084	0.913	0.8	2.15	-	6	0	0	100%	0.9167
3TH3_BGC_L_203	54%	56%	0.151	0.915	0.62	1.08	-	1	1	0	100%	0.9167
1DAN_BGC_L_153	47%	26%	0.152	0.892	1.27	1.71	1	1	1	0	100%	0.9167
8UUD_BGC_L_201	45%	70%	0.157	0.887	0.4	0.73	-	-	0	0	100%	0.9167
1W0Y_BGC_L_1161	41%	18%	0.164	0.878	0.96	2.56	1	7	0	0	100%	0.9167
1HHU_BGC_C_8	100%	67%	0.037	0.997	0.6	0.68	-	-	0	0	100%	0.9167
9G11_BGC_A_601	100%	46%	0.037	0.995	1.24	0.84	1	-	1	0	100%	1
4IIG_BGC_B_950	100%	50%	0.035	0.987	0.78	1.13	-	2	1	0	100%	1
2V3G_BGC_A_1281	100%	68%	0.051	0.994	0.52	0.69	-	-	0	0	100%	1
5DNF_BGC_A_102	100%	26%	0.047	0.988	2.1	0.95	3	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.